Boehringer Ingelheim and University of Dundee extend PROTAC Drug Discovery Program
Boehringer Ingelheim and Dundee extend ongoing anti-cancer alliance Boehringer Ingelheim and University of Dundee achieve milestone in collaboration aimed at developing novel protein degradation medicines...










